SEC Form 4 · accession 0001104659-15-008723
NPS PHARMACEUTICALS INC · NPSP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susan E Graf
Officer — VP, Corp Development & Strateg
Period of report
Feb 10, 2015
Accepted (ET)
Feb 11, 2015 · 12:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890465
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 10, 2015 | M | 6,711 | $14.90 | A | 10,511 | D | |
| Common Stock | Feb 10, 2015 | S | 6,711 | $45.8701 | D | 3,800 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Options (right to buy)F1 | $14.90 | Feb 10, 2015 | M | 6,711 | D | — | Jun 17, 2023 | Common Stock | 6,711 | 41,289 | D |
Explanation of responses
- F1On June 17, 2013, the reporting person received a grant of 48,000 stock options under NPS Pharmaceuticals Inc.'s amended and restated 2005 Omnibus Incentive Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the date of grant and 6.25% every three months thereafter.